- Breaking News Comtec Solar and Neo Solar Power Launch the 'Perfect Wafer' Embedded 'Perfect Cell'
- Breaking News Ask Amy: He Backs Out Over Ban on Gay Marriage
- Breaking News Rumble dots
- Breaking News Pride of service
CancerVax Corporation announces corporate restructuring and Crucell to release third quarter results on Monday, October 17.
0 Comments | M2 Presswire, October, 2005
M2 PRESSWIRE-4 October 2005-US Financial Network: CancerVax Corporation announces corporate restructuring and Crucell to release third quarter results on Monday, October 17(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:04102005 City of Industry, CA - Biotechnoly industry news provided by Financial News USA (OTC: FNWU) CancerVax Corporation (NASDAQ: CNVX) announced a corporate restructuring plan today, realigning its resources in light of its decision to discontinue the Phase 3 clinical trial of Canvaxin(TM) in patients with Stage III melanoma.
The immediate impact of this restructuring will reduce CancerVax's workforce from 183 to approximately 80 employees. Dutch biotechnology company Crucell N.V. (Nasdaq: CRXL) recently announced that it will release its...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Traction Named #1 Interactive Agency for 2009 by BtoB Magazine
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- A multi-class SVM classifier utilizing binary decision tree
- Taylor Fund L.P. Gains 40.53% in Third Quarter